UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

The Journal of infectious diseases, 2009-03, Vol.199 (5), p.693-701

2009

Volltextzugriff (PDF)

Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use

PloS one, 2009-06, Vol.4 (6), p.e6079-e6079

2009

Volltextzugriff (PDF)

HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China

PloS one, 2016-02, Vol.11 (2), p.e0149215-e0149215

2016

Volltextzugriff (PDF)

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

AIDS (London), 2012-01, Vol.26 (2), p.185-192

2012

Volltextzugriff (PDF)

Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype After Virologic Failure

The Journal of infectious diseases, 2013-03, Vol.207 (6), p.893-897

2013

Volltextzugriff (PDF)

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations

PloS one, 2012-07, Vol.7 (7), p.e40514-e40514

2012

Volltextzugriff (PDF)

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China

PloS one, 2014-06, Vol.9 (6), p.e98740-e98740

2014

Volltextzugriff (PDF)

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

JAMA : the journal of the American Medical Association, 2011-04, Vol.305 (13), p.1327

2011

Volltextzugriff (PDF)

Fostemsavir: a first-in-class HIV-1 attachment inhibitor

Current opinion in HIV & AIDS, 2022-01, Vol.17 (1), p.32-35

2022

Volltextzugriff (PDF)

Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam

Clinical infectious diseases, 2011-04, Vol.52 (7), p.945-952

2011

Volltextzugriff (PDF)

Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance

Antiviral therapy, 2007-01, Vol.12 (4), p.563-570

2007

Volltextzugriff (PDF)

Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects

Viruses, 2014-09, Vol.6 (9), p.3428-3437

2014

Volltextzugriff (PDF)

Deep Sequencing of HIV: Clinical and Research Applications

Annual review of genomics and human genetics, 2014-01, Vol.15 (1), p.295-325

2014

Volltextzugriff (PDF)

Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals

AIDS (London), 2022-02, Vol.36 (2), p.205-214

2022

Volltextzugriff (PDF)

Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study

HIV medicine, 2024-02, Vol.25 (2), p.212-222

2024

Volltextzugriff (PDF)

Transmission of HIV drug resistance: lessons from sensitive screening assays

Current opinion in infectious diseases, 2015-02, Vol.28 (1), p.23-30

2015

Volltextzugriff (PDF)

Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection

Journal of Virus Eradication, 2015-10, Vol.1 (4), p.264-268

2015

Volltextzugriff (PDF)

Review: Hepatitis C Protease and Polymerase Inhibitors in Development

AIDS patient care and STDs, 2008-06, Vol.22 (6), p.449-457

2008

Volltextzugriff (PDF)

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

The Lancet (British edition), 2006-12, Vol.368 (9553), p.2125-2135

2006

Volltextzugriff (PDF)

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies

AIDS (London), 2007-07, Vol.21 (12), p.1579-1589

2007

Volltextzugriff (PDF)

Hepatitis C protease and polymerase inhibitors in development

AIDS patient care and STDs, 2008-06, Vol.22 (6), p.449

2008

Volltextzugriff (PDF)

The hunt for HIV-1 integrase inhibitors

AIDS patient care and STDs, 2006-07, Vol.20 (7), p.489-501

2006

Volltextzugriff (PDF)

Use of new technologies to detect and understand HIV drug resistance

Retrovirology, 2010-05, Vol.7 (S1), p.I19-I19, Article I19

Kozal, Michael J

2010

Volltextzugriff (PDF)

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays

Nature medicine, 1996-07, Vol.2 (7), p.753-759

1996

Volltextzugriff (PDF)

Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care

AIDS (London), 2004-11, Vol.18 (16), p.2185-2189

2004

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(75)

Sprache

Englisch
(75)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use

HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype After Virologic Failure

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

Fostemsavir: a first-in-class HIV-1 attachment inhibitor

Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam

Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance

Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects

Deep Sequencing of HIV: Clinical and Research Applications

Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals

Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study

Transmission of HIV drug resistance: lessons from sensitive screening assays

Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection

Review: Hepatitis C Protease and Polymerase Inhibitors in Development

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies

Hepatitis C protease and polymerase inhibitors in development

The hunt for HIV-1 integrase inhibitors

Use of new technologies to detect and understand HIV drug resistance

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays

Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care

Suchergebnisse filtern